Senate Bill Aims To Restrict Authorized Generics
By Jessica Dye ( February 17, 2011, 2:24 PM EST) -- U.S. Senate Democrats are reviving a proposal to restrict brand-name pharmaceutical companies' ability to market authorized generics during the 180-day exclusivity window following the first successful challenge to a brand patent by a generic-drug maker....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.